Bipolar limbic expression of auto-immune thyroid targets: thyroglobulin and thyroid-stimulating hormone receptor.

Abstract:

:The associations between thyroid auto-immunity and neuro-psychiatric disorders are well-documented. However, there exists limited literature specifically linking auto-immune thyroid disease (AITD) to bipolar disorder (BD). Thus, we investigated the likely association between Hashimoto's disease and BD through the extra-thyroidal localisation of thyroid-stimulating hormone receptor (TSH-R) and thyroglobulin (TG) in limbic regions of normal and bipolar human adult brain. Further, we hypothesised that changes in thyroid expression in bipolar limbic cortex may contribute to mood dysregulation associated with BD. Immuno-chemistry and in-situ PCR were used to localise TSH-R/TG within the amygdala, cingulate gyrus and frontal cortex of normal (n = 5) and bipolar (n = 5) brains. Reverse-transcriptase qPCR provided fold-change differences in TSH-R gene expression. The results demonstrated reduced thyroid protein expression in bipolar limbic regions; these novel results correlate with other neuro-imaging reports that describe reduced cortico-limbic tissue volumes and neuro-physiological activity during BD. We also demonstrated TG-like proteins exclusive to bipolar amygdala neurons, and which relates to previous neuro-imaging studies of amygdala hyperactivity and enhanced emotional sensitivity in BD. Indeed, reduced TSH-R/TG in limbic regions may predispose to, or bear relevance in the pathophysiology of mood dysregulation and symptoms of BD. Further, we attribute mood dysregulation in BD to limbic-derived TSH-R, which probably provides potential targets for thyroid auto-immune factors during Hashimoto's disease. Consequently, this may lead to inactivated and/or damaged neurons. The neuro-pathology of diminished neuronal functioning or neuronal atrophy suggests a novel neuro-degeneration mechanism in BD.

journal_name

Metab Brain Dis

journal_title

Metabolic brain disease

authors

Naicker M,Abbai N,Naidoo S

doi

10.1007/s11011-019-00437-w

subject

Has Abstract

pub_date

2019-10-01 00:00:00

pages

1281-1298

issue

5

eissn

0885-7490

issn

1573-7365

pii

10.1007/s11011-019-00437-w

journal_volume

34

pub_type

杂志文章
  • Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.

    abstract::Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by accumulation and deposition of Aβ peptide in human brain. The present study aimed to determine the protective effect of catechin rich extract of MERM (methanolic extract of Rhizophora mucronata) on Aβ (25-35) induced cognitive impai...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-016-9831-0

    authors: Suganthy N,Malar DS,Devi KP

    更新日期:2016-08-01 00:00:00

  • Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.

    abstract::Traumatic brain injury (TBI) is accompanied with enhanced matrix metalloproteinase-9 (MMP-9) activity and elevated levels of plasma fibrinogen (Fg), which is a known inflammatory agent. Activation of MMP-9 and increase in blood content of Fg (i.e. hyperfibrinogenemia, HFg) both contribute to cerebrovascular disorders ...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-014-9550-3

    authors: Muradashvili N,Benton RL,Saatman KE,Tyagi SC,Lominadze D

    更新日期:2015-04-01 00:00:00

  • Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study.

    abstract::The associations of levels of apolipoprotein A1 (ApoA1) and apolipoprotein B and ApoB/A1 ratio and risk of a first stroke have not been reliably documented. We performed a meta-analysis to summarize the relationships and confirmed them in a case-control study. We identified relevant publications in PubMed and Embase d...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s11011-015-9732-7

    authors: Dong H,Chen W,Wang X,Pi F,Wu Y,Pang S,Xie Y,Xia F,Zhang Q

    更新日期:2015-12-01 00:00:00

  • Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease.

    abstract::We investigated the biochemical alterations of the striatum of mice subjected to seven experimental schedules with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) treatment. The mice were treated intraperitoneally (i.p.) with MPTP (20 mg/kg in saline) four times a day at 2-hr intervals showed severe ...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-010-9195-9

    authors: Kuroiwa H,Yokoyama H,Kimoto H,Kato H,Araki T

    更新日期:2010-06-01 00:00:00

  • Cortical benzodiazepine receptor binding in a rabbit model of hepatic encephalopathy: the effect of Triton X-100 on receptor solubilization.

    abstract::Increased benzodiazepine (BZ) receptor density has been reported in brains of rabbits with hepatic encephalopathy (HE) due to galactosamine (GalN)-induced fulminant hepatic failure (FHF). These data were generated using detergent-Triton X-100-treated neural membranes. While performing further studies it was noted that...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/BF01000296

    authors: Rössle M,Mullen KD,Jones EA

    更新日期:1989-09-01 00:00:00

  • High mobility group box 1 enhances hyperthermia-induced seizures and secondary epilepsy associated with prolonged hyperthermia-induced seizures in developing rats.

    abstract::Levels of high mobility group box 1 (HMGB1), an important inflammatory mediator, are high in the serum of febrile seizure (FS) patients. However, its roles in FS and secondary epilepsy after prolonged FS are poorly understood. We demonstrate HMGB1's role in the pathogenesis of hyperthermia-induced seizures (HS) and se...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-017-0103-4

    authors: Ito M,Takahashi H,Yano H,Shimizu YI,Yano Y,Ishizaki Y,Tanaka J,Ishii E,Fukuda M

    更新日期:2017-12-01 00:00:00

  • EGb761 improves the cognitive function of elderly db/db-/- diabetic mice by regulating the beclin-1 and NF-κB signaling pathways.

    abstract::To assess whether EGb761 could protect elderly diabetic mice with cognitive disorders and explore the role of beclin-1-mediated autophagy in these protective effects. Two-month-old male db/db-/- mice and wild-type C57/BL6 mice were randomly divided into six groups: db/db-/- control, db/db-/- 50 mg, db/db-/- 100 mg, wi...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-018-0295-2

    authors: Guan ZF,Zhang XM,Tao YH,Zhang Y,Huang YY,Chen G,Tang WJ,Ji G,Guo QL,Liu M,Zhang Q,Wang NN,Yu ZY,Hao-Yang,Wu GF,Tang ZP,Du ZG,Shang XL,Liu YC,Mei GH,Guo JC,Zhou HG

    更新日期:2018-12-01 00:00:00

  • Hydroxychloroquine effects on miR-155-3p and miR-219 expression changes in animal model of multiple sclerosis.

    abstract::Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system which causes chronic demyelination. Hydroxychloroquine (HCQ) possess immunosuppressive and anti-inflammatory properties. The aim of this study was to investigate the effect of HCQ on miR-219 and miR-155-3p expression changes in MS-...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-020-00609-z

    authors: Mazloumfard F,Mirian M,Eftekhari SM,Aliomrani M

    更新日期:2020-12-01 00:00:00

  • Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.

    abstract::It has been suggested that alterations of GABAergic neurotransmission are implicated in the pathophysiology of hepatic encephalopathy (HE). Increased concentrations of endogenous benzodiazepines with positive allosteric modulatory properties at the GABA-A receptor complex were proposed as a pathophysiological mechanis...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1023/b:mebr.0000043974.89820.22

    authors: Ahboucha S,Pomier-Layrargues G,Butterworth RF

    更新日期:2004-12-01 00:00:00

  • MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.

    abstract::Methamphetamine (METH) is a highly addictive psycho-stimulant that induces behavioral changes due to high level of METH-induced dopamine in the brain. Nucleus accumbens (NAc) plays an important role in these changes, especially in drug addiction. However, little is known about the underlying molecular mechanisms of ME...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-017-0061-x

    authors: Sim MS,Soga T,Pandy V,Wu YS,Parhar IS,Mohamed Z

    更新日期:2017-12-01 00:00:00

  • The neuroprotective effect of berberine in mercury-induced neurotoxicity in rats.

    abstract::The central nervous system is one of the most vulnerable organs affected by mercury toxicity. Both acute and chronic exposure to mercury is also known to cause a variety of neurological or psychiatric disorders. Here, the neuroprotective effect of berberine (BN; 100 mg/kg bwt) on mercuric chloride (HgCl2; 0.4 mg/kg bw...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-015-9652-6

    authors: Abdel Moneim AE

    更新日期:2015-08-01 00:00:00

  • Near infrared radiation rescues mitochondrial dysfunction in cortical neurons after oxygen-glucose deprivation.

    abstract::Near infrared radiation (NIR) is known to penetrate and affect biological systems in multiple ways. Recently, a series of experimental studies suggested that low intensity NIR may protect neuronal cells against a wide range of insults that mimic diseases such as stroke, brain trauma and neurodegeneration. However, the...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-014-9515-6

    authors: Yu Z,Liu N,Zhao J,Li Y,McCarthy TJ,Tedford CE,Lo EH,Wang X

    更新日期:2015-04-01 00:00:00

  • Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion.

    abstract::Transient bilateral common carotid artery occlusion (tBCCAO), followed by reperfusion, is a model of transient global hypoperfusion. In the present study we aimed to investigate the probable effects of Vanillic acid (VA) on some physiological parameters including cerebral hyperemia, blood-brain barrier (BBB) disruptio...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-018-0187-5

    authors: Khoshnam SE,Farbood Y,Fathi Moghaddam H,Sarkaki A,Badavi M,Khorsandi L

    更新日期:2018-06-01 00:00:00

  • The association of sleep-disordered breathing and white matter hyperintensities in heart failure patients.

    abstract::Heart failure patients often manifest white matter hyperintensites on brain magnetic resonance imaging (MRI). White matter hyperintnsities have also been linked with cognitive problems in patients with heart failure. Sleep disordered breathing may contribute to structural brain changes in heart failure. The purpose of...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-018-0309-0

    authors: Moon C,Bendlin BB,Melah KE,Bratzke LC

    更新日期:2018-12-01 00:00:00

  • Dietary supplementation of undernourished rats with soy or safflower oil: effects on myelin polyunsaturated fatty acids.

    abstract::Undernourished suckling rats were administered, by gastric intubation, either soy oil (which is rich in both linoleic and linolenic acids) or safflower oil (which is rich in linoleic acid but deficient in linolenic acid) to determine (1) if dietary supplementation would offset the hypomyelination characteristic of the...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/BF00999385

    authors: Divakaran P,Pavlina T,Johnson RC,Cotter R,Madsen D,Wiggins R

    更新日期:1986-06-01 00:00:00

  • Antioxidant treatment strategies for hyperphenylalaninemia.

    abstract::Hyperphenylalaninemia (HPA) leads to increased oxidative stress in patients with phenylketonuria (PKU) and in animal models of PKU. Early diagnosis and immediate adherence to a phenylalanine-restricted diet prevents HPA and, consequently, severe brain damage. However, treated adolescent and adult PKU patients have dif...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1007/s11011-013-9414-2

    authors: Mazzola PN,Karikas GA,Schulpis KH,Dutra-Filho CS

    更新日期:2013-12-01 00:00:00

  • The role of the MAP-kinase superfamily in beta-amyloid toxicity.

    abstract::The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of t...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1023/a:1012541011123

    authors: Daniels WM,Hendricks J,Salie R,Taljaard JJ

    更新日期:2001-12-01 00:00:00

  • Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency.

    abstract::Adult-onset type II citrullinemia (CTLN2), characterized by a liver-specific deficiency of urea cycle enzyme, argininosuccinate synthetase, is caused by mutations in SLC25A13 that encodes a calcium binding mitochondrial solute carrier protein, citrin. Citrin deficiency causes not only CTLN2 but also neonatal intrahepa...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1023/a:1021961919148

    authors: Saheki T,Kobayashi K,Iijima M,Nishi I,Yasuda T,Yamaguchi N,Gao HZ,Jalil MA,Begum L,Li MX

    更新日期:2002-12-01 00:00:00

  • Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

    abstract::Hepatic encephalopathy (HE) is an important cause of morbidity and mortality in patients with severe liver disease. Although the molecular basis for the neurological disorder in HE remains elusive, elevated ammonia and its chief metabolite glutamine are believed to be important factors responsible for altered cerebral...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1023/a:1011666612822

    authors: Rao KV,Norenberg MD

    更新日期:2001-06-01 00:00:00

  • Advances in intervention methods and brain protection mechanisms of in situ and remote ischemic postconditioning.

    abstract::Ischemic postconditioning (PostC) conventionally refers to a series of brief blood vessel occlusions and reperfusions, which can induce an endogenous neuroprotective effect and reduce cerebral ischemia/reperfusion (I/R) injury. Depending on the site of adaptive ischemic intervention, PostC can be classified as in situ...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1007/s11011-020-00562-x

    authors: Li CY,Ma W,Liu KP,Yang JW,Wang XB,Wu Z,Zhang T,Wang JW,Liu W,Liu J,Liang Y,Zhang XK,Li JJ,Guo JH,Li LY

    更新日期:2021-01-01 00:00:00

  • Brain edema: a valid endpoint for measuring hepatic encephalopathy?

    abstract::Hepatic encephalopathy (HE) is a major complication of liver failure/disease which frequently develops during the progression of end-stage liver disease. This metabolic neuropsychiatric syndrome involves a spectrum of symptoms, including cognition impairment, attention deficits and motor dysfunction which eventually c...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1007/s11011-016-9843-9

    authors: Bémeur C,Cudalbu C,Dam G,Thrane AS,Cooper AJ,Rose CF

    更新日期:2016-12-01 00:00:00

  • Predominant gray matter volume loss in patients with end-stage renal disease: a voxel-based morphometry study.

    abstract::To investigate the pattern of brain volume changes in patients with end-stage renal disease (ESRD) using voxel-based morphometry (VBM) and correlation with clinical and neuropsychological (NP) tests. Fifty seven ESRD patients with no anatomical abnormalities in conventional magnetic resonance imaging [24 patients with...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-013-9438-7

    authors: Zhang LJ,Wen J,Ni L,Zhong J,Liang X,Zheng G,Lu GM

    更新日期:2013-12-01 00:00:00

  • Wilson disease.

    abstract::Wilson disease (WD) is an autosomal recessive inherited disorder of copper metabolism, resulting in pathological accumulation of copper in many organs and tissues. The hallmarks of the disease are the presence of liver disease, neurologic symptoms, and Kayser-Fleischer corneal rings. The leading neurologic symptoms in...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1007/s11011-005-7910-8

    authors: Kitzberger R,Madl C,Ferenci P

    更新日期:2005-12-01 00:00:00

  • Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.

    abstract::Depression, common in chronic medical conditions, and hepatic encephalopathy (HE), a reversible neuropsychiatric syndrome due to liver dysfunction, are associated with impaired health-related quality of life (HRQOL) in cirrhosis and hepatitis C (HCV). This study investigated the impact of depression and HE on HRQOL in...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-016-9817-y

    authors: Barboza KC,Salinas LM,Sahebjam F,Jesudian AB,Weisberg IL,Sigal SH

    更新日期:2016-08-01 00:00:00

  • Synergistic antidepressant-like effect of ferulic acid in combination with piperine: involvement of monoaminergic system.

    abstract::The lifetime prevalence rate for major depressive disorder (MDD) is approximately 17 % for most developed countries around the world. Dietary polyphenols are currently used as an adjuvant therapy to accelerate the therapeutic efficacy on depression. Ferulic acid (FA) or 4-hydroxy-3-methoxy-cinnamic acid (Fig. 1a) is a...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-015-9704-y

    authors: Li G,Ruan L,Chen R,Wang R,Xie X,Zhang M,Chen L,Yan Q,Reed M,Chen J,Xu Y,Pan J,Huang W

    更新日期:2015-12-01 00:00:00

  • Decrease of glutathione content in the prefrontal cortical mitochondria of rats with acute hepatic encephalopathy: prevention by histidine.

    abstract::Mitochondrial glutathione (mGSH) is a critical factor in the cell defense against oxidative and nitrosative stress (ONS), and ONS is a key pathogenic event in hepatic encephalopathy (HE). Acute HE in the thioacetamide (TAA) model caused a 54 % decrease of mGSH content in the rat prefrontal cortex (pfc), but not in the...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-012-9342-6

    authors: Ruszkiewicz J,Fręśko I,Hilgier W,Albrecht J

    更新日期:2013-03-01 00:00:00

  • Promising outcomes in glutaric aciduria type I patients detected by newborn screening.

    abstract::Glutaric aciduria type I (GA-I) is an inborn error of lysine and tryptophan metabolism. Clinical manifestations of GA-I include dystonic or dyskinetic cerebral palsy, but when the symptoms occur, treatment is not effective. In Taiwan, newborn screening for GA-I started in 2001; we wish to evaluate the outcomes of pati...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-012-9349-z

    authors: Lee CS,Chien YH,Peng SF,Cheng PW,Chang LM,Huang AC,Hwu WL,Lee NC

    更新日期:2013-03-01 00:00:00

  • Thiamine triphosphate: a ubiquitous molecule in search of a physiological role.

    abstract::Thiamine triphosphate (ThTP) was discovered over 60 years ago and it was long thought to be a specifically neuroactive compound. Its presence in most cell types, from bacteria to mammals, would suggest a more general role but this remains undefined. In contrast to thiamine diphosphate (ThDP), ThTP is not a coenzyme. I...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章,评审

    doi:10.1007/s11011-014-9509-4

    authors: Bettendorff L,Lakaye B,Kohn G,Wins P

    更新日期:2014-12-01 00:00:00

  • Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.

    abstract::The role of oxidative stress in the pathogenesis of phenylketonuria (PKU)-associated disorders has been implicated. Ischemia modified albumin (IMA) is a modified form of serum albumin, which is produced under the conditions of oxidative stress. The aim of this study was to measure the serum level of IMA in the PKU pat...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-017-0165-3

    authors: Keshavarzi F,Rastegar M,Vessal M,Rafiei Dehbidi G,Khorsand M,Ganjkarimi AH,Takhshid MA

    更新日期:2018-06-01 00:00:00

  • Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine.

    abstract::Parkinson's disease is a neurodegenerative disease whose hallmark pathological features include a selective loss of dopaminergic neurons in the midbrain. Ciclooxygenase-2 activity induction and oxidative stress have been implicated in the aetiology of Parkinson's disease and in the 1-methyl-4-phenyl-1,2,3,6-tetrahydro...

    journal_title:Metabolic brain disease

    pub_type: 杂志文章

    doi:10.1007/s11011-013-9416-0

    authors: Ortiz GG,Pacheco-Moisés FP,Gómez-Rodríguez VM,González-Renovato ED,Torres-Sánchez ED,Ramírez-Anguiano AC

    更新日期:2013-12-01 00:00:00